459 related articles for article (PubMed ID: 25643592)
1. Emerging oral drugs for psoriasis.
Mahmood T; Zaghi D; Menter A
Expert Opin Emerg Drugs; 2015 Jun; 20(2):209-20. PubMed ID: 25643592
[TBL] [Abstract][Full Text] [Related]
2. Emerging topical treatments for psoriasis.
Kivelevitch DN; Hebeler KR; Patel M; Menter A
Expert Opin Emerg Drugs; 2013 Dec; 18(4):523-32. PubMed ID: 24274614
[TBL] [Abstract][Full Text] [Related]
3. Apremilast for the management of moderate to severe plaque psoriasis.
Vangipuram R; Alikhan A
Expert Rev Clin Pharmacol; 2017 Apr; 10(4):349-360. PubMed ID: 28276777
[TBL] [Abstract][Full Text] [Related]
4. Combining biologic therapies with other systemic treatments in psoriasis: evidence-based, best-practice recommendations from the Medical Board of the National Psoriasis Foundation.
Armstrong AW; Bagel J; Van Voorhees AS; Robertson AD; Yamauchi PS
JAMA Dermatol; 2015 Apr; 151(4):432-8. PubMed ID: 25517130
[TBL] [Abstract][Full Text] [Related]
5. Use of Apremilast in Combination With Other Therapies for Treatment of Chronic Plaque Psoriasis: A Retrospective Study.
AbuHilal M; Walsh S; Shear N
J Cutan Med Surg; 2016 Jul; 20(4):313-6. PubMed ID: 26848145
[TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis.
Bianchi L; Del Duca E; Romanelli M; Saraceno R; Chimenti S; Chiricozzi A
Expert Opin Drug Metab Toxicol; 2016 Sep; 12(9):1121-8. PubMed ID: 27376729
[TBL] [Abstract][Full Text] [Related]
7. Apremilast as a treatment for psoriasis.
Shutty B; West C; Pellerin M; Feldman S
Expert Opin Pharmacother; 2012 Aug; 13(12):1761-70. PubMed ID: 22712800
[TBL] [Abstract][Full Text] [Related]
8. Long-term efficacy of biologics in the treatment of psoriasis: what do we really know?
Alwawi EA; Krulig E; Gordon KB
Dermatol Ther; 2009; 22(5):431-40. PubMed ID: 19845720
[TBL] [Abstract][Full Text] [Related]
9. Safety evaluation of apremilast for the treatment of psoriasis.
Dattola A; Del Duca E; Saraceno R; Gramiccia T; Bianchi L
Expert Opin Drug Saf; 2017 Mar; 16(3):381-385. PubMed ID: 28132578
[TBL] [Abstract][Full Text] [Related]
10. A review of emerging IL-17 inhibitors in the treatment of psoriasis focusing on preclinical through phase II studies.
Campa M; Menter A
Expert Opin Investig Drugs; 2016 Nov; 25(11):1337-1344. PubMed ID: 27687859
[TBL] [Abstract][Full Text] [Related]
11. Psoriasis.
Burfield L; Burden AD
J R Coll Physicians Edinb; 2013; 43(4):334-8; quiz 339. PubMed ID: 24350319
[TBL] [Abstract][Full Text] [Related]
12. Drug safety evaluation of apremilast for treating psoriatic arthritis.
Busa S; Kavanaugh A
Expert Opin Drug Saf; 2015 Jun; 14(6):979-85. PubMed ID: 25827658
[TBL] [Abstract][Full Text] [Related]
13. [Psoriasis].
Navarini AA; Trüeb RM
Ther Umsch; 2010 Apr; 67(4):153-65. PubMed ID: 20336615
[TBL] [Abstract][Full Text] [Related]
14. Pediatric psoriasis: updates in biologic therapies.
Sukhatme SV; Gottlieb AB
Dermatol Ther; 2009; 22(1):34-9. PubMed ID: 19222515
[TBL] [Abstract][Full Text] [Related]
15. Oral Psoriasis Therapies.
James J; Otto T; Gao J; Porter ML
Dermatol Clin; 2024 Jul; 42(3):357-363. PubMed ID: 38796267
[TBL] [Abstract][Full Text] [Related]
16. New topical treatments for psoriasis.
Chiricozzi A; Pitocco R; Saraceno R; Nistico SP; Giunta A; Chimenti S
Expert Opin Pharmacother; 2014 Mar; 15(4):461-70. PubMed ID: 24392930
[TBL] [Abstract][Full Text] [Related]
17. Improvement of Nail and Scalp Psoriasis Using Apremilast in Patients With Chronic Psoriasis: Phase 2b and 3, 52-Week Randomized, Placebo-Controlled Trial Results.
Nguyen CM; Leon A; Danesh M; Beroukhim K; Wu JJ; Koo J
J Drugs Dermatol; 2016 Mar; 15(3):272-6. PubMed ID: 26954311
[TBL] [Abstract][Full Text] [Related]
18. An update on the safety of apremilast for the treatment of plaque psoriasis.
Shavit E; Shear NH
Expert Opin Drug Saf; 2020 Apr; 19(4):403-408. PubMed ID: 32182143
[No Abstract] [Full Text] [Related]
19. Favorable response to apremilast in a patient with refractory psoriasis verrucosa.
Okazaki S; Osawa R; Nakajima H; Nakajima K; Sano S
J Dermatol; 2019 Jun; 46(6):544-547. PubMed ID: 30957901
[TBL] [Abstract][Full Text] [Related]
20. The status of biologic therapies in the treatment of moderate to severe psoriasis.
Menter A
Cutis; 2009 Oct; 84(4 Suppl):14-24. PubMed ID: 19916298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
